Home/Innovent Biologics/Dr. Michael Yu (Dezheng Yu)
DM

Dr. Michael Yu (Dezheng Yu)

Founder, Chairman, CEO & President

Innovent Biologics

Innovent Biologics Pipeline

DrugIndicationPhase
Tyvyt (sintilimab)Various CancersApproved
Byvasda (bevacizumab biosimilar)Various CancersApproved
IBI-306HypercholesterolemiaNDA Submitted
IBI-362Type 2 Diabetes/ObesityPhase 3
IBI-310Various CancersPhase 3
IBI-326Multiple MyelomaPhase 1/2
IBI-322Advanced Solid TumorsPhase 1/2
IBI-323Advanced Solid TumorsPhase 1/2